Evidence map›Paper›PMID 39380157›Full record

ArticleFEBS open bio2024

Cylindracin, a Cys-rich protein expressed in the fruiting body of Cyclocybe cylindracea, inhibits growth of filamentous fungi but not yeasts or bacteria.

Yamato Kuratani, Chika Abematsu, Keisuke Ekino, Takuji Oka, Masashi Shin, Makoto Iwata, Hiroto Ohta, Shoji Ando

Abstract read
In one paragraph

Article in FEBS open bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yamato KurataniFaculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.
Chika AbematsuFaculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.
Keisuke EkinoFaculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.
Takuji OkaFaculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-5691-654X
Masashi ShinFaculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.
Makoto IwataIMB Co., Ltd., Asakura, Japan.
Hiroto OhtaFaculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.
Shoji AndoFaculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-9237-2711

Funding

Sojo University
6 · The paper itself

Abstract

Mushrooms are the fruiting bodies of fungi and are important reproductive structures that produce and disseminate spores. The Pri3 gene was originally reported to be specifically expressed in the primordia (a precursor to the mature fruiting body) of the edible mushroom Cyclocybe aegerita. Here, we cloned a Pri3-related cDNA from Cyclocybe cylindracea, another species in the same genus, and showed that the gene is specifically expressed at the pileus surface of the immature fruiting body but not in the primordia. Immunohistochemistry showed that the translated protein is secreted into a polysaccharide layer of the pileus surface. The recombinant C-terminal Cys-rich domain of the protein showed antifungal activity against three filamentous fungi and inhibited hyphal growth and conidiogenesis. These results suggest that the PRI3-related protein of C. cylindracea, named cylindracin, plays an important role in the defense against pathogens.

Indexed as

AgaricalesFruiting Bodies, FungalFungal ProteinsAmino Acid SequenceAntifungal AgentsBacteriaCysteineFungiYeastsAntifungal AgentsCysteineFungal Proteinsantifungal proteinBasidiomycetesCyclocybe cylindraceacylindracinhost defensePri3

Identifiers

PMID39380157
PMCPMC11532979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.